Related references
Note: Only part of the references are listed.International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes et al.
PHARMACOLOGICAL REVIEWS (2021)
Structure-Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update
Maria N. Modica et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery of β-Arrestin Biased Ligands of 5-HT7R
Youngjae Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Biased signalling: from simple switches to allosteric microprocessors
Jeffrey S. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Structure and dynamics of GPCR signaling complexes
Daniel Hilger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Structure and dynamics of GPCR signaling complexes
Daniel Hilger et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions
Enza Lacivita et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling
Yuri K. Peterson et al.
PHARMACOLOGICAL REVIEWS (2017)
G protein-coupled receptor kinases: Past, present and future
Konstantin E. Komolov et al.
CELLULAR SIGNALLING (2017)
Selective 5-HT7 Receptor Activation May Enhance Synaptic Plasticity Through N-methyl-D-aspartate (NMDA) Receptor Activity in the Visual Cortex
Kangjian Xiang et al.
CURRENT NEUROVASCULAR RESEARCH (2016)
5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity
Youngjae Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
THE SEROTONIN SYSTEM IN AUTISM SPECTRUM DISORDER: FROM BIOMARKER TO ANIMAL MODELS
C. L. Muller et al.
NEUROSCIENCE (2016)
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models
Clinton E. Canal et al.
ACS CHEMICAL NEUROSCIENCE (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Wesley K. Kroeze et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome
Bianca De Filippis et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory
Oliver Stiedl et al.
FRONTIERS IN PHARMACOLOGY (2015)
PDZ Protein Regulation of G Protein-Coupled Receptor Trafficking and Signaling Pathways
Henry A. Dunn et al.
MOLECULAR PHARMACOLOGY (2015)
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome
Bianca De Filippis et al.
NEUROPSYCHOPHARMACOLOGY (2014)
A Real-Time Method for Measuring cAMP Production Modulated by Gαi/o-Coupled Metabotropic Glutamate Receptors
John O. DiRaddo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Terry Kenakin et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Joao Peca et al.
NATURE (2011)
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
Marcello Leopoldo et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Heterotrimeric G Protein Signaling Outside the Realm of Seven Transmembrane Domain Receptors
Caroline Marty et al.
MOLECULAR PHARMACOLOGY (2010)
5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice
Alex Brenchat et al.
PAIN (2009)
The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation
A. Meneses et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Serotonin type 1D receptors (5HT1DR) are differentially distributed in nerve fibres innervating craniofacial tissues
A. M. Harriott et al.
CEPHALALGIA (2008)
The genetic design of signaling cascades to record receptor activation
Gilad Barnea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders
Latha Soorya et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2008)
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Christelle M. Durand et al.
NATURE GENETICS (2007)
Oxidative iodination of deactivated arenes in concentrated sulfuric acid with I2/NaIO4 and KI/NaIO4 iodinating systems
L Kraszkiewicz et al.
SYNTHESIS-STUTTGART (2006)
Easy, inexpensive and effective oxidative iodination of deactivated arenes in sulfuric acid
L Kraszkiewicz et al.
TETRAHEDRON (2004)
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology
DA Shapiro et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist
JJ Hagan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Genetic evaluation of pervasive developmental disorders: the terminal 22q13 deletion syndrome may represent a recognizable phenotype
C Prasad et al.
CLINICAL GENETICS (2000)
Share Paper
